Post procedural myocardial infarction

Also known as: Periprocedural myocardial infarction

DrugDrug NameDrug Description
DB06441CangrelorA P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST).
DrugDrug NameTargetType
DB06441CangrelorP2Y purinoceptor 12target
DrugDrug NamePhaseStatusCount
DB00758Clopidogrel4Completed1
DB08816Ticagrelor4Completed1